Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tisdale

Showing results (151-160 of 307) with videos related to

Pageof 31
Sort By:
Biochemical Pharmacology|November 1, 1976
The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cellsM J Tisdale, B J Phillips
British Journal of Cancer|November 1, 1988
A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia modelM J Tisdale, R A Brennan
British Journal of Cancer|May 1, 1991
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomasH D Mulligan, M J Tisdale
Biochemical Pharmacology|July 15, 1984
Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451)C M Horgan, M J Tisdale
British Journal of Cancer|February 1, 1983
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissuesM J Tisdale, R A Brennan
Biochemical Pharmacology|January 15, 1985
Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitroC M Horgan, M J Tisdale
Endocrinology|August 21, 2012
Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG)Steven T Russell, Michael J Tisdale
Cellular Signalling|March 4, 2025
ERK activation by Rab2B in the early secretory pathway impacts the ERGIC-Golgi interfaceEllen J Tisdale, Cristina R Artalejo
Journal of Personality Assessment|January 1, 1990
MCMI characteristics of DSM-III-R bulimicsM J Tisdale, L Pendleton, M Marler
British Journal of Cancer|June 13, 2001
Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradationB S Islam-Ali, M J Tisdale
Pageof 31

Showing results (151-160 of 307) with videos related to

Sort By:
Pageof 31
Biochemical Pharmacology|November 1, 1976
The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cellsM J Tisdale, B J Phillips
British Journal of Cancer|November 1, 1988
A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia modelM J Tisdale, R A Brennan
British Journal of Cancer|May 1, 1991
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomasH D Mulligan, M J Tisdale
Biochemical Pharmacology|July 15, 1984
Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451)C M Horgan, M J Tisdale
British Journal of Cancer|February 1, 1983
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissuesM J Tisdale, R A Brennan
Biochemical Pharmacology|January 15, 1985
Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitroC M Horgan, M J Tisdale
Endocrinology|August 21, 2012
Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG)Steven T Russell, Michael J Tisdale
Cellular Signalling|March 4, 2025
ERK activation by Rab2B in the early secretory pathway impacts the ERGIC-Golgi interfaceEllen J Tisdale, Cristina R Artalejo
Journal of Personality Assessment|January 1, 1990
MCMI characteristics of DSM-III-R bulimicsM J Tisdale, L Pendleton, M Marler
British Journal of Cancer|June 13, 2001
Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradationB S Islam-Ali, M J Tisdale
Pageof 31